Scholar Rock Holding Corporation (NASDAQ:SRRK) Advances Toward Potential Approval; Near-Term Volatility Likely
![]() |
Pipeline progress around apitegromab and recent regulatory alignment brighten the clinical outlook while technical indicators show mixed momentum, implying short-term swings against a stretched valuation. |









